Desmoid Fibromatosis
📧 Sign up to get email alerts when something new happens for Desmoid Fibromatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study of AL102 in Patients With Progressing Desmoid Tumors [Phase 2, Phase 3]
Clinical trial update for AL102 in progressing desmoid tumors, currently active/not recruiting across Phase 2 and Phase 3.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery [Phase 2]
A Phase 2 clinical trial evaluating Nirogacestat for desmoid tumors that are unresectable or recurrent, currently listed as active not recru…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Project: Every Child for Younger Patients With Cancer
Clinical trial update from the Children's Oncology Group shows that the multi-indication pediatric trial 'Project: Every Child for Younger P…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Treatment of Desmoid Fibromatosis With Arterial Embolization
Clinical trial update for Desmoid fibromatosis examining arterial embolization as a treatment. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis [Phase 2]
Phase 2 trial evaluating doxorubicin-eluting intra-arterial embolization for aggressive desmoid fibromatosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis [Phase 3]
Phase 3 trial of sorafenib tosylate in desmoid fibromatosis (desmoid tumors) completed with posted results.